This company listing is no longer active
Volpara Health Technologies Balance Sheet Health
Financial Health criteria checks 5/6
Volpara Health Technologies has a total shareholder equity of NZ$47.9M and total debt of NZ$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NZ$80.1M and NZ$32.2M respectively.
Key information
0%
Debt to equity ratio
NZ$0
Debt
| Interest coverage ratio | n/a |
| Cash | NZ$13.19m |
| Equity | NZ$47.90m |
| Total liabilities | NZ$32.22m |
| Total assets | NZ$80.12m |
Recent financial health updates
We're Hopeful That Volpara Health Technologies (ASX:VHT) Will Use Its Cash Wisely
Mar 06
Does Volpara Health Technologies (ASX:VHT) Have A Healthy Balance Sheet?
Mar 24Volpara Health Technologies (ASX:VHT) Is Using Debt Safely
Dec 24Recent updates
What Volpara Health Technologies Limited's (ASX:VHT) 52% Share Price Gain Is Not Telling You
Dec 19We're Hopeful That Volpara Health Technologies (ASX:VHT) Will Use Its Cash Wisely
Mar 06Calculating The Intrinsic Value Of Volpara Health Technologies Limited (ASX:VHT)
Jun 03Does Volpara Health Technologies (ASX:VHT) Have A Healthy Balance Sheet?
Mar 24Volpara Health Technologies (ASX:VHT) Shareholders Booked A 93% Gain In The Last Three Years
Jan 28Volpara Health Technologies (ASX:VHT) Is Using Debt Safely
Dec 24Here's What We Think About Volpara Health Technologies' (ASX:VHT) CEO Pay
Nov 19
Financial Position Analysis
Short Term Liabilities: VHT's short term assets (NZ$27.7M) do not cover its short term liabilities (NZ$31.5M).
Long Term Liabilities: VHT's short term assets (NZ$27.7M) exceed its long term liabilities (NZ$754.0K).
Debt to Equity History and Analysis
Debt Level: VHT is debt free.
Reducing Debt: VHT had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable VHT has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: VHT is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 3.1% per year.
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/05/21 09:59 |
| End of Day Share Price | 2024/05/16 00:00 |
| Earnings | 2023/09/30 |
| Annual Earnings | 2023/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Volpara Health Technologies Limited is covered by 6 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Russell Wright | Barclay Pearce Capital Pty Limited |
| John Hester | Bell Potter |
| Russell Wright | Maqro Capital |